These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4301862)

  • 1. [On ways of reducing the toxic effects of antitumorous preparations].
    Monakhov BV
    Vopr Onkol; 1968; 14(8):101-12. PubMed ID: 4301862
    [No Abstract]   [Full Text] [Related]  

  • 2. [Side-effects of cytostatic therapy with special reference to potential carcinogenic effects].
    Schmähl D
    Internist (Berl); 1971; 12():Suppl 1:115-9. PubMed ID: 5002614
    [No Abstract]   [Full Text] [Related]  

  • 3. [The hypoplastic state of hematopoiesis following chemotherapy with alkylating compounds].
    Kholodnyi MD; Mindlin SS
    Vopr Onkol; 1969; 15(8):27-32. PubMed ID: 4982329
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experimental basis for methods of determining individual sensitivity of tumors to alkylating antitumor preparations].
    Kulik GI
    Biull Eksp Biol Med; 1969 Dec; 68(12):68-70. PubMed ID: 4986230
    [No Abstract]   [Full Text] [Related]  

  • 5. [Quantitative evaluation of the efficacy of antineoplastic agents].
    Karavainova MKh
    Farmakol Toksikol; 1971; 34(5):618-21. PubMed ID: 5004886
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effect of antineoplastic alkylating agents on the serum protein fraction of rats with sarcoma 45].
    Kulik GI; Pel'kis FP
    Vopr Onkol; 1969; 15(7):68-71. PubMed ID: 4980425
    [No Abstract]   [Full Text] [Related]  

  • 7. Carcinogenicity of anticancer drugs and especially alkylating agents.
    Schmähl D
    IARC Sci Publ; 1986; (78):29-35. PubMed ID: 3583394
    [No Abstract]   [Full Text] [Related]  

  • 8. [Carcinogenic effects of antineoplastic and immunosuppressive agents].
    Brock N; Schneider H
    Arzneimittelforschung; 1971 Sep; 21(9):1406-10. PubMed ID: 5171799
    [No Abstract]   [Full Text] [Related]  

  • 9. [Molecular mechanisms of the occurrence of tumor drug resistance and ways to overcome it].
    Belousova AK
    Vopr Onkol; 1978; 24(5):92-104. PubMed ID: 351956
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ways to overcome the contradictions between the experimental and clinical chemotherapy of tumors].
    Syrkin AB
    Vopr Onkol; 1990; 36(6):740-4. PubMed ID: 2378096
    [No Abstract]   [Full Text] [Related]  

  • 11. Antitumor drug toxicity: implications for response and for survival.
    Nahhas WA; Hall TC; Sherman CD; Savlov ED
    Am J Med Sci; 1969 Oct; 258(4):245-59. PubMed ID: 5823461
    [No Abstract]   [Full Text] [Related]  

  • 12. [The possibility of local cytostatic therapy].
    Grundmann E
    HNO; 1966 May; 14(5):129-33. PubMed ID: 5987279
    [No Abstract]   [Full Text] [Related]  

  • 13. [The role of results of animal experiments in clinical tumor chemotherapy].
    Sugár J; Somfai-Relle Z; Németh L
    Orv Hetil; 1980 Jul; 121(29):1745-52. PubMed ID: 7454286
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experimental studies on the carcinogenic effects of anticancer chemotherapeutics and immunosuppressive agents].
    Schmähl D; Osswald H
    Arzneimittelforschung; 1970 Oct; 20(10):1461-7. PubMed ID: 5536412
    [No Abstract]   [Full Text] [Related]  

  • 15. An outline of cancer chemotherapy.
    Connors TA
    Rev Roum Inframicrobiol; 1971; 8(3):135-51. PubMed ID: 5152643
    [No Abstract]   [Full Text] [Related]  

  • 16. Carcinogenicity of alkylating cytostatic drugs. Proceedings of a symposium. Heidelberg, Federal Republic of Germany, 25-27 November 1985.
    IARC Sci Publ; 1986; (78):1-338. PubMed ID: 3583383
    [No Abstract]   [Full Text] [Related]  

  • 17. [The cancerogenicity of antineoplastic agents].
    Rieche K
    Arch Geschwulstforsch; 1969; 34(2):240-54. PubMed ID: 4920118
    [No Abstract]   [Full Text] [Related]  

  • 18. [Molecular basis of the relation between the cytotoxic effect of antineoplastic compounds and the cell cycle phase].
    Belousova AK
    Vopr Onkol; 1972; 18(8):88-96. PubMed ID: 4348595
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of zymosan on the toxicity and activity of various antitumor preparations].
    Veksler IG
    Vopr Onkol; 1966; 12(8):80-6. PubMed ID: 4972211
    [No Abstract]   [Full Text] [Related]  

  • 20. [Adverse events and those managements of alkylating agents].
    Matsuoka H
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():139-42. PubMed ID: 25831738
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.